Summary
TransDigm Group Incorporated (TDG) reported strong financial results for the thirteen-week period ended December 28, 2024. Net sales increased by 12.1% year-over-year to $2,006 million, driven by robust organic sales growth in defense and commercial aftermarket segments, along with contributions from recent acquisitions. Net income attributable to TD Group surged by 29.1% to $493 million, reflecting improved gross profit margins and controlled operating expenses. The company also demonstrated solid operational cash flow generation, providing $752 million. Key drivers for the period include sustained strong demand in the commercial aftermarket, benefiting from increased flight hours, and continued improvement in U.S. Government defense spending. While commercial OEM sales saw a slight decrease due to production disruptions, the overall business performance was positive. TransDigm maintained a healthy EBITDA As Defined margin of 52.9%, underscoring its operational efficiency and value-driven strategy. The company ended the quarter with substantial liquidity, including $2,459 million in cash and cash equivalents, positioning it well for ongoing operations and strategic initiatives.
Financial Highlights
53 data points| Revenue | $2.01B |
| Cost of Revenue | $771.00M |
| Gross Profit | $1.24B |
| SG&A Expenses | $211.00M |
| Operating Income | $974.00M |
| Net Income | $493.00M |
| EPS (Basic) | $7.62 |
| EPS (Diluted) | $7.62 |
| Shares Outstanding (Basic) | 58.30M |
| Shares Outstanding (Diluted) | 58.30M |
Key Highlights
- 1Net sales increased 12.1% to $2,006 million, driven by 6.6% organic sales growth and contributions from acquisitions.
- 2Net income attributable to TD Group surged 29.1% to $493 million, with EPS rising to $7.62 from $4.87 in the prior year.
- 3Operating cash flow was strong at $752 million, an increase from $636 million in the prior year's comparable period.
- 4EBITDA As Defined reached $1,061 million, a 16.3% increase, with a healthy margin of 52.9% of net sales.
- 5Significant acquisitions in fiscal 2024, including Raptor Scientific and CPI's Electron Device Business, are contributing positively to revenue and segment performance.
- 6The company repurchased $316 million of common stock during the quarter under its existing repurchase program.
- 7TransDigm ended the period with $2,459 million in cash and cash equivalents, indicating strong liquidity.